First do no harm: an analysis of the risk aspects and side effects of clinical holistic medicine compared with standard psychiatric biomedical treatment.
Clinical holistic medicine (CHM) is short-term psychodynamic psychotherapy (STPP) complemented with bodywork and philosophical exercises, to be more efficient in treating patients with severe mental and physical illness. STPP has already been found superior to psychiatric treatment as usual (TAU) and thus able to compete with psychiatric standard treatment as the treatment of choice for all non-organic mental illnesses; we have found the addition of bodywork and philosophy of life to STPP to accelerate the process of existential healing and recovery (salutogenesis). In this paper we compare the side effects, suicidal risk, problems from implanted memory and implanted philosophy of CHM with psychopharmacological treatment.


METHODS
Qualitative and quantitative comparative review.


RESULTS
In all aspects of risks, harmfulness, and side effects, we have been considering, CHM was superior to the standard psychiatric treatment. The old principle of "first do no harm" is well respected by CHM, but not always by standard psychiatry. CHM seems to be able to heal the patient, while psychopharmacological drugs can turn the patient into a chronic, mentally ill patient for life. Based on the available data CHM seems another alternative to patients with mental illness. There seem to be no documentation at all for CHM being dangerous, harmful, having side effects of putting patients at risk for suicide. As CHM uses spontaneous regression there is no danger for the patient developing psychosis as, according to some experts, has been seen with earlier intensive psychodynamic methods. CHM is an efficient, safe and affordable cure for a broad range of mental illnesses.
Ventegodt
Søren
S
Quality of Life Research Center, DK-1452 Copenhagen K, Denmark. ventegodt@livskvalitet.org
Kandel
Isack
I
Merrick
Joav
J
D000328:Adult; D005260:Female; D006694:Holistic Health; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000401:mortality* / Q000628:therapy*; D015995:Prevalence; D011613:Psychotherapy / Q000706:statistics & numerical data*; D018570:Risk Assessment / Q000379:methods*; D012307:Risk Factors; D013405:Suicide; D016019:Survival Analysis; D015996:Survival Rate; D014481:United States